SPDR S&P Biotech ETF
397 hedge funds and large institutions have $3.88B invested in SPDR S&P Biotech ETF in 2017 Q4 according to their latest regulatory filings, with 93 funds opening new positions, 124 increasing their positions, 112 reducing their positions, and 43 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
397
Holders Change
+48
Holders Change %
+13.75%
% of All Funds
9.02%
Holding in Top 10
17
Holding in Top 10 Change
-1
Holding in Top 10 Change %
-5.56%
% of All Funds
0.39%
New
93
Increased
124
Reduced
112
Closed
43
Calls
$537M
Puts
$1.85B
Net Calls
-$1.31B
Net Calls Change
-$575M
Top Buyers
| 1 |
UBS Group
Zurich,
Switzerland
|
$256M |
| 2 |
Citigroup
New York
|
$535M |
| 3 |
AllianceBernstein
Nashville,
Tennessee
|
$75.5M |
| 4 |
Barclays
London,
United Kingdom
|
$70.1M |
| 5 |
Bank of America
Charlotte,
North Carolina
|
$263M |
